top of page

Lynn Yap

The Altruistic Capitalist

Frosted Glass Texture

Strategic Board Advisor to Health Tech CEOs

I support founders and leadership teams building AI-enabled healthcare products that earn patient trust, drive real-world adoption, and scale sustainably across markets.

 

Senior commercial and strategic perspective — without the commitment of a full-time executive hire.

When Companies Bring Me In

Health technology companies often reach a pivotal moment where the technology is proven — but scaling requires more than performance metrics.

CEOs typically reach out when:

 

  • Patient adoption is uneven despite strong clinical or technical validation

  • Trust, communication, and experience have become business-critical

  • Growth is accelerating, but strategic focus is needed

  • Expansion beyond the home market introduces new complexity

  • The founder wants a trusted external partner at leadership level

  • The organisation is moving from early traction into a more structured scaling phase

 

This is often the stage where senior external perspective can help leadership teams make clearer commercial decisions and build the foundations for sustainable growth.

How I Help

As a board advisor, I work alongside CEOs on the strategic and commercial decisions that shape the next stage of the business — particularly where patient trust and adoption are essential to long-term success.

 

Support often includes:

 

  • Patient-centred go-to-market and positioning

  • Scaling from early traction into repeatable growth

  • Partnerships and routes to market within healthcare ecosystems

  • International expansion across Europe and beyond

  • Building trust in AI-enabled care and diagnostics

 

Engagements are focused, practical, and designed for real leadership leverage.

About

LYNN_YAP_Headshot_min.jpg

I’m Lynn Yap, and I work with founders and leadership teams in health technology as a strategic board advisor during key moments of growth and transition.

 

My focus is supporting CEOs building AI-enabled healthcare products where long-term success depends not only on technical validation, but on patient trust, adoption, and clear commercial strategy.

 

I bring senior commercial and operational experience across global businesses including Avon, Estée Lauder, and Adidas, supporting growth strategy, transformation, and new market entry. I hold an MBA from The Wharton School and have board-level experience working with leadership teams through scaling challenges.

 

Today, I am increasingly focused on advising digital health and patient-facing healthcare platforms — bringing a consumer lens to the adoption of AI-driven innovation in complex and highly regulated environments.

 

I advise through my independent practice, The Altruistic Capitalist, reflecting a commitment to building businesses that scale through trust, responsible innovation, and long-term value creation.

 

I work with a small number of companies each year, offering focused board-level support without the commitment of a full-time executive hire.

Areas of Focus

Leaders typically bring me in to strengthen commercial clarity, scaling execution, and trust-driven adoption.

 

Selected outcomes include:

 

  • Supported international growth and commercial transformation across global businesses including Avon, Estée Lauder, and Adidas
     

  • Improved profitability by approximately 10% through pricing and resource allocation decisions
     

  • Reduced marketing spend by approximately 15% while maintaining commercial performance
     

  • Brought a consumer trust lens to scaling technology-led products in complex and highly regulated environments.
     

Selected Outcomes

estee-lauder-companies-logo.png

Leaders typically bring me in to strengthen commercial clarity, scaling execution, and trust-driven adoption.

 

Selected outcomes include:

 

  • Supported international growth and commercial transformation across global businesses including Avon, Estée Lauder, and Adidas

  • Improved profitability by approximately 10% through pricing and resource allocation decisions

  • Reduced marketing spend by approximately 15% while maintaining commercial performance

  • Brought a consumer trust lens to scaling technology-led products in complex and highly regulated environments

Adidas-Logo-1991.png

What Leaders Say

“Lynn brings exceptional strategic clarity and a rare ability to understand complex ecosystems. Her impact reshaped Avon’s omnichannel and sustainability strategy.”

Angela Cretu, CEO, Avon International

"Lynn combines strong strategic judgement with an inclusive leadership style, helping teams make thoughtful collective decisions.”

Kief Ho, CEO, The Southover Partnership

Advisory Structure

Engagements are typically structured as:

 

  • A monthly advisory retainer (cash, with optional equity alignment)

  • A cadence of 2 days per month up to 1 day per week

  • Support tailored to the CEO’s priorities and growth stage

 

I work with a small number of companies each year to ensure depth and impact.

Contact

If you’re leading a health tech company through a growth transition — particularly where patient trust and adoption are central — I’d be happy to connect.

Or, if easier:

 

Based in Switzerland, working with leadership teams across Europe and the US.

bottom of page